Wolfgang Miesbach
9PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 29, 2023
An open-label, multi-centre, post-marketing study to assess the efficacy and safety of a plasma-derived VWF/FVIII concentrate in patients with von Willebrand disease.Wolfgang Miesbach, Susan Halimeh, Helen Platokouki
|Oct 11, 2023
Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapy.Ana Boban, Fariba Baghaei, Fijnvandraat Karin
|Feb 24, 2023
Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial.Frank W G Leebeek, Flora Peyvandi, Andreas Tiede
|Dec 27, 2022
Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy.Sebastian E Koschade, Jan A Stratmann, Björn Steffen
|Sep 16, 2022
Endothelial dysfunction and atherosclerosis related miRNA-expression in patients with haemophilia.Stephanie Noone, Ralf Schubert, Stephan Fichtlscherer
|Oct 20, 2021
Implications of haemophilia gene therapy for the changing role of the multidisciplinary team.Wolfgang Miesbach, Sara Garcia Barcenilla, Gaby Golan
Pageof 2
Frequent Collaborators
3 joint publications
Flora Peyvandi
3 joint publications
Miguel Escobar
2 joint publications
Pratima Chowdary
2 joint publications
Robert Klamroth
2 joint publications
Johnny Mahlangu
2 joint publications
Giancarlo Castaman
2 joint publications
Michael Wang
1 joint publications
Daniel P Hart
1 joint publications
Ingrid Pabinger
1 joint publications
Michael Makris
